Invention Grant
- Patent Title: Anticancer composition comprising obovatol or obovatal
- Patent Title (中): 抗肿瘤药物组合物包含奥泊芬或obovatal
-
Application No.: US12194230Application Date: 2008-08-19
-
Publication No.: US08367736B2Publication Date: 2013-02-05
- Inventor: Byoung-Mog Kwon , Kwang-Hee Son , Dong-Cho Han , Su-Kyung Lee , Jung-Min Kim , Young-Hee Kho , Hyo-Kon Chun , Jae-Young Yang
- Applicant: Byoung-Mog Kwon , Kwang-Hee Son , Dong-Cho Han , Su-Kyung Lee , Jung-Min Kim , Young-Hee Kho , Hyo-Kon Chun , Jae-Young Yang
- Applicant Address: KR Daejeon
- Assignee: Korea Research Institute of Bioscience and Biotechnology
- Current Assignee: Korea Research Institute of Bioscience and Biotechnology
- Current Assignee Address: KR Daejeon
- Agency: Casimir Jones, S.C.
- Priority: KR10-2005-0073915 20050811
- Main IPC: A61K31/11
- IPC: A61K31/11
Abstract:
Disclosed herein is an anticancer composition, comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof. The composition exhibits the activity of inhibiting the growth of cancer cells and suppressing the expression and activity of matrix metalloproteinases (MMPs), and thus can be useful for the prophylaxis and treatment of cancer as well as for the inhibition of cancer metastasis.
Public/Granted literature
- US20080312337A1 Anticancer Composition Comprising Obovatol or Obovatal Public/Granted day:2008-12-18
Information query
